The Latest Breaking News from VillageMD

Public health and private equity: What the Walgreens buyout could mean for the future of pharmacy care

Pharmacies are more than just stores – they’re vital links between people and their health care.

The Conversation · May 28, 2025

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

MarketBeat · Mar 11, 2025

Is Walgreens Stock a Buy Thanks to Its Fat 9% Dividend Yield?

Walgreens (WBA) is attempting to turn around its struggling business with a new strategic vision and leadership, offering an enticing 10.7% dividend yield

Barchart · Jan 16, 2025

Walgreens aims to cut more costs amid weaker demand for COVID vaccines, uncertain economy

Walgreens Boots Alliance is raising its cost-savings goal by 17% to $4.1 billion after a disappointing quarter — a move that comes just weeks after it said it was eliminating 10% of its corporate workforce.

Chicago Tribune · Jun 27, 2023

CVS buying Chicago’s Oak Street Health in deal valued at $10.6 billion

CHICAGO — CVS Health plans to buy Chicago-based Oak Street Health in a $10.6 billion deal that aims to expand CVS’s reach into primary care.

Chicago Tribune · Feb 8, 2023

CVS buys Chicago-based Oak Street Health for $10.6B

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

Chicago Sun-Times · Feb 8, 2023

Walgreens’ VillageMD buys another urgent and primary care chain for $9 billion

Walgreens and rival CVS have evolved in recent years far beyond their historic focus on store sales and filling prescriptions.

Chicago Sun-Times · Nov 7, 2022

Chicago-based VillageMD to pay $8.9 billion to acquire care provider, with help from Walgreens

Chicago-based VillageMD, which has primary care clinics in Walgreens stores across the country, will pay $8.9 billion to acquire a company that will help it to branch into specialty and urgent care and grow its footprint dramatically.

Chicago Tribune · Nov 7, 2022

Tesla Explored Minority Stake In Glencore, TuSimple Fires Its CEO Amid Regulatory Scrutiny, Twitter Could Reportedly Lose A Fourth Of Its Employees After Takeover: Top Stories Monday, Oct. 31

Washington Post

Benzinga · Oct 31, 2022

RBC Says This Pharmacy Chain Has Health Investments On Track Despite Abandoning Divestiture

RBC Capital Markets lowered the price target on Walgreens Boots Alliance Inc (NASDAQ:WBA) to $42 (10% upside) from $46 and maintained the Sector Perform rating. The analysts say that WBA posted solid fiscal 3Q22 results slightly ahead of their estimates and consensus on steady execution in the U.S. against a difficult comp and continued…

Benzinga · Jul 5, 2022